American Journal of Kidney Diseases
Volume 53, Issue 1 , Pages 5-8 , January 2009

IgA Nephropathy: A Disease in Search of a Large-Scale Clinical Trial to Reliably Inform Practice

  • Giovanni F.M. Strippoli, MD, PhD, MPH (Hons), MM (Epi)

      Affiliations

    • Mario Negri Sud Consortium, Chieti, Italy
    • Diaverum Medical-Scientific Office, Lund, Sweden
    • Cochrane Renal Group, Sydney, Australia
    • University of Sydney, Sydney, Australia
    • Corresponding Author InformationAddress correspondence to Giovanni F. M. Strippoli, NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, University of Sydney, Australia
    • ,
  • Ausilia Maione, MSc PharmChem

      Affiliations

    • Mario Negri Sud Consortium, Chieti, Italy
    • ,
  • Francesco P. Schena, MD

      Affiliations

    • University of Bari, Italy, Bari, Italy
    • ,
  • G. Tognoni, MD

      Affiliations

    • Mario Negri Sud Consortium, Chieti, Italy
    • ,
  • Jonathan C. Craig, MD, PhD, MM (Clin Epi)

      Affiliations

    • Cochrane Renal Group, Sydney, Australia
    • University of Sydney, Sydney, Australia

  • Image Result

    Effect of corticosteroids versus comparator treatments on doubling of creatinine in patients with IgA nephropathy.

    Effect of corticosteroids versus comparator treatments on doubling of creatinine in patients with IgA nephropathy.

  • Image Result

    Effect of corticosteroids versus comparator treatments on proteinuria in patients with IgA nephropathy.

    Effect of corticosteroids versus comparator treatments on proteinuria in patients with IgA nephropathy.

PII: S0272-6386(08)01563-1

doi: 10.1053/j.ajkd.2008.10.035

American Journal of Kidney Diseases
Volume 53, Issue 1 , Pages 5-8 , January 2009

Article Tools

* Image Usage & Resolution